Safety and tolerability of injectable Rilpivirine LA in HPTN 076: a phase 2 HIV Pre-exposure prophylaxis study in women
Written By
Bekker LG, Li S, Pathak S, Tolley EE, Marzinke MA, Justman JE, Mgodi NM, Chirenje M, Swaminathan S, Adeyeye A, Farrior J, Hendrix CW, Piwowar-Manning E, Richardson P, Eshelman SH, Redinger H, Williams P, Sista ND, HPTN 076 Study Team
